A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4

被引:7
作者
Hewson, TJ
Logie, JJ
Simmonds, P
Howie, SEM
机构
[1] Univ Edinburgh, Sch Med, Dept Pathol, Edinburgh EH8 9AG, Midlothian, Scotland
[2] Univ Edinburgh, Ctr Res Inflammat Res, Immunobiol Grp, Edinburgh EH8 9YL, Midlothian, Scotland
[3] Univ Edinburgh, Lab Clin & Mol Virol, Edinburgh EH8 9YL, Midlothian, Scotland
关键词
D O I
10.4049/jimmunol.166.8.4835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type I HIV gp120 is especially effective in disrupting immune cell function because it is able to cause dysregulation of both infected and uninfected cells. We report a novel CCR5-dependent mechanism of gp120-induced CD4 loss from macrophages. An M-tropic gp120, using CCR5, is able to induce 70% loss of cell surface CD4 from macrophages within an hour. This cell surface CD4 loss is more substantial and rapid than the 20% loss observed with T-tropic gp120(IIIB) by 3 h. The rapid and substantial CD4 loss induced by M-tropic gp120 is not observed on macrophages homozygous for the cer5 Delta 32 mutation, which fail to express cell surface CCR5. We have used confocal imaging to show that gp120 and CD4 are internalized together by a process resembling receptor-mediated endocytosis, and that both proteins enter HLA-DR containing compartments of the macrophage. We have also shown by semiquantitative RT-PCR that, in response to CD4 loss from the cell surface, mRNA for CD4 is up-regulated and the intracellular pool of CD4 increases. CCR5 mRNA levels are also increased. It is proposed that internalization of self and viral protein and increased pools of intracellular CD4 could modulate Ag presentation efficiencies and have implications for the induction and maintenance of both productive immune responses and self-tolerance.
引用
收藏
页码:4835 / 4842
页数:8
相关论文
共 55 条
[1]  
BARRESINOUSSI F, 1988, LYMPHOLOGY, V21, P11
[2]   CD4: A co-receptor in the immune response and HIV infection [J].
Bowers, K ;
Pitcher, C ;
Marsh, M .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (06) :871-875
[3]   Autoimmune T-cell response to the CD4 molecule in HIV-infected patients [J].
Caporossi, AP ;
Bruno, G ;
Salemi, S ;
Mastroianni, C ;
Falciano, M ;
Salotti, A ;
Bergami, N ;
Santilio, I ;
Nisini, R ;
Barnaba, V .
VIRAL IMMUNOLOGY, 1998, 11 (01) :9-17
[4]   Interleukin 16 and its function as a CD4 ligand [J].
Center, DM ;
Kornfeld, H ;
Cruikshank, WW .
IMMUNOLOGY TODAY, 1996, 17 (10) :476-481
[5]   INTERLEUKIN-12 - A BRIDGE BETWEEN INNATE RESISTANCE AND ADAPTIVE IMMUNITY WITH A ROLE IN INFECTION AND ACQUIRED IMMUNODEFICIENCY [J].
CHEHIMI, J ;
TRINCHIERI, G .
JOURNAL OF CLINICAL IMMUNOLOGY, 1994, 14 (03) :149-161
[6]   Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions [J].
Chirmule, N ;
Pahwa, S .
MICROBIOLOGICAL REVIEWS, 1996, 60 (02) :386-+
[7]   Chemokine receptors in HIV-1 and SIV infection [J].
Choe, H .
ARCHIVES OF PHARMACAL RESEARCH, 1998, 21 (06) :634-639
[8]   Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome [J].
Coyle, TE .
MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (02) :449-+
[9]   Adenovirus-mediated human immunodeficiency virus-1 nef expression in human monocytes/macrophages and effect of nef on downmodulation of Fcγ receptors and expression of monokines [J].
De, SK ;
Venkateshan, CNS ;
Seth, P ;
Gajdusek, DC ;
Gibbs, CJ .
BLOOD, 1998, 91 (06) :2108-2117
[10]   MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION [J].
DEJONG, JJ ;
DERONDE, A ;
KEULEN, W ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6777-6780